Skip to main content
. 2018 Jun 4;15(8):3404–3416. doi: 10.1021/acs.molpharmaceut.8b00407

Figure 5.

Figure 5

Immunoblotting of apoptotic markers and cell signaling proteins in (A,B) A549 cells; C) HL60 cells. Cells were treated with 20 μM of compound 1 for specified time periods; cisplatin (20 μM) and doxorubicin (2 μM) at 24 h of treatment were used as controls. GAPDH was used as the loading control.